Centerline Biomedical is a private medical technology company that commercializes vascular navigation technology. Founded in 2014 as a spinoff of the Cleveland Clinic, the company traces its research, development and design history to the Clinic's Lerner Research Institute Heart and Vascular Institute. Its core product is the IOPS platform, developed for vascular navigation. The IOPS platform can also be used for predictive modeling, clinical decision support, global healthcare analytics and the education and training of future surgeons and interventionists. Centerline announced the closing of a $33 million Series B equity financing led by Cleveland Clinic, with participation from GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures and G2 Group Ventures. The company is based in Cleveland, OH. Centerline Biomedical is a Cleveland Clinic spinout commercializing the IOPS™ platform for interventional imaging. The platform is designed to improve patient and caregiver safety, reduce procedure time, and limit harmful radiation and contrast dye. It also aims to lower costs for healthcare systems while improving access to care. The company raised $10M in financing to enhance its team and accelerate commercialization. Limited launch commercialization was planned for Q2 2020, with a full launch in the second half of 2020. Centerline is hiring key talent, including a Head of R&D and Head of Operations, to support rollout. Centerline Biomedical develops a proprietary surgical vascular navigation system based on research from the Cleveland Clinic’s Heart & Vascular Institute. The technology aims to reduce radiation exposure to patients and caregivers while giving surgeons a GPS-like tool to improve safety and accuracy. The platform first targets the endovascular aneurysm repair market and the company plans to address a variety of additional vascular procedures. Centerline intends to use recently raised funds to advance the system to the next phase of development and continue testing. The company was founded in November 2014 and is led by CEO William Fuller. It is based in Cleveland, OH.

Total raised

$45M

Funding rounds

3

Latest round

Series B

Latest activity

Jun 2022